WorldPingNPR Top
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
WorldPingResearchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
This is a short WorldPing brief. The full report was published by NPR Top.
Read the full report at NPR Top